Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 4_suppl, Pages 327-327

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2019-01-30

DOI

10.1200/jco.2019.37.4_suppl.327

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now